Drugs / Inactivated EBV-infected vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00278200 | Jan 2003 → Aug 2012 | lymphoproliferative syndrome | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated EBV-infected vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00278200 ↗ |
| Modality | Vaccine | “photochemically-treated autologous Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cell vaccine” NCT00278200 ↗ |